LB Pharmaceuticals Inc Common Stock
LB Pharmaceuticals Inc Common Stock (LBRX) Stock Forecast & Analyst Price Target
Wall Street consensus, 12-month price targets, model projections, and EPS/revenue estimates — from analyst data and price history.
lbrx · stock forecast · 1 analysts (3M) · FMP · updated Jun 8, 2026
Analyst Rating & Consensus
Based on 1 Wall Street analysts in the past 3 months
Buy
1 analysts
consensus
Rating Breakdown
12-Month Price Target
High
$45.00
Consensus
$39.50
+37.4% upside
Low
$36.00
Median: $38.5 · Last Close: $28.75
12-Month Price Target Forecast
Historical closing prices + analyst 12-month price target forecast cone
Consensus Target
$39.50
37.4% upside
High Target
$45
56.5%
Low Target
$36
25.2%
Current Price
$28.75
as of today
Based on analyst price targets, the LBRX stock price prediction for the next 12 months ranges from $36 to $45. The consensus LBRX price forecast of $39.50 implies 37.4% upside from the current price of $28.75.
Short-Term Price Prediction
Algorithmically generated · Updated daily
| Date | Predicted Price | Change |
|---|---|---|
| 2026-06-09 | $28.28 | ↓ 1.62% |
1-day model range: $28.14–$28.43. Peak: $28.43 (-1.62%).
Long-Term Stock Price Prediction
Stock Forecast Based on Technical Analysis
14 TA signals (SMA×6 + EMA×6 + RSI + MACD) · EEAT method transparency
Market Sentiment
BULLISH
Based on 14 technical indicators
Refreshes daily from EOD close
Moving Averages · LBRX · Jun 8, 2026
Latest Analyst Ratings & Upgrades
| Date | Brokerage | Action | Rating |
|---|---|---|---|
| 2026-03-27 | Stifel | Maintains | Buy→Buy |
| 2025-12-11 | Stifel | Maintains | Buy→Buy |
Wall Street analysts have recently issued updated ratings on LB Pharmaceuticals Inc Common Stock (LBRX) stock. Of the recent 2 rating actions, 0 were upgrades and 0 were downgrades. 1 analysts currently cover LBRX.
Analyst Recommendation Trends
LBRX analyst recommendation trends show stable buy-side sentiment over the past 6 months. Buy rating actions changed from 1 to 1 per month.
Financial Forecast: EPS & Revenue Estimates
Revenue This Year
$0M
Revenue Next Year
$0M
EPS This Year
$-3.52
EPS Next Year
$-4.39
↑ 24.5% YoY
EPS ForecastReported vs Estimated
Analysts forecast LBRX EPS of $-3.52 for the current fiscal year, based on estimates from 5 analysts. The LBRX revenue forecast is $0M for the current year. These are analyst consensus estimates via FMP / S&P Global.
About Forecast & Price Prediction
The LBRX stock forecast is supported by two independent data sources: analyst consensus ratings from 1 Wall Street analysts (S&P Global / FMP), and technical analysis calculated from historical EOD price data. The consensus LBRX price target is $39.50 (+37.4% upside), with an analyst consensus of Buy.
The LBRX short-term stock prediction for tomorrow is $28.28 (-1.62%).
LB Pharmaceuticals Inc Common Stock trades on NASDAQ under the ticker LBRX. The LBRX stock outlook for 2027 is broadly positive, supported by a Buy consensus among 100% of covering analysts.
Frequently asked questions
LBRX forecast · 8 questionsAccording to 1 Wall Street analysts, the average 12-month LBRX price target is $39.50, with a high forecast of $45.00 and a low of $36.00. The median price target is shown in the chart above when available. This implies +37.4% potential upside from the current price of $28.75.
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.